| 临床病理特征 | n (%) | 存活人数 (n = ) n% | 死亡人数 (n = ) n% | Log-rank检验 | |
| χ2 | P值 | ||||
| HER-2表达 |
|
|
| 0.329 | 0.566 |
| 阴性 | 30 (50.0) | 19 (47.5) | 11 (55.0) | ||
| 阳性 | 30 (50.0) | 21 (52.5) | 9 (45.0) | ||
| 年龄 |
|
|
| 0.010 | 0.921 |
| ≤64 | 32 (53.3) | 21 (52.5) | 11 (55.0) | ||
| >64 | 28 (46.7) | 19 (47.5) | 9 (45.0) | ||
| 性别 |
|
|
| 0.352 | 0.553 |
| 男 | 38 (63.3) | 27 (67.5) | 11 (55.0) | ||
| 女 | 22 (36.7) | 13 (32.5) | 9 (45.0) | ||
| 浸润程度 |
|
|
| 1.867 | 0.172 |
| T1~T2 | 15 (25.0) | 12 (30.0) | 3 (15.0) | ||
| T3~T4 | 45 (75.0) | 28 (70.0) | 17 (85.0) | ||
| 淋巴结转移 |
|
|
| 4.565 | 0.033 |
| 无 | 21 (35.0) | 19 (47.5) | 2 (10.0) | ||
| 有 | 39 (65.0) | 21 (52.5) | 18 (90.0) | ||
| 远处转移(腹水涂片阳性) |
|
|
| 0.072 | 0.788 |
| 无 | 54 (90.0) | 36 (90.0) | 18 (90.0) | ||
| 有 | 6 (10.0) | 4 (10.0) | 2 (10.0) | ||
| TNM分期 |
|
|
| 3.977 | 0.046 |
| I期~II期 | 27 (45.0) | 22 (55.0) | 5 (25.0) | ||
| III期~IV期 | 33 (55.0) | 18 (45.0) | 15 (75.0) | ||
| Laurens分型 |
|
|
| 0.092 | 0.955 |
| 肠型 | 29 (48.3) | 19 (47.5) | 10 (50.0) | ||
| 混合型 | 20 (33.3) | 14 (35.0) | 6 (30.0) | ||
| 弥漫型 | 11 (18.3) | 7 (17.5) | 4 (20.0) | ||
| 分化程度 |
|
|
| 0.980 | 0.322 |
| 低分化 | 33 (55.0) | 20 (50.0) | 13 (65.0) | ||
| 中分化 | 27 (45.0) | 20 (50.0) | 7 (35.0) | ||
| 神经侵犯 |
|
|
| 1.052 | 0.305 |
| 无 | 23 (38.3) | 17 (42.5) | 6 (30.0) | ||
| 有 | 37 (61.7) | 23 (57.5) | 14 (70.0) | ||